Thermo Scientific™

LanthaScreen™ PRAS40 293E Cell Line

The PI3K/AKT pathway is activated by various stimuli (including insulin and IGF-1) and mediates signals for cell growth, cell survival,자세히 알아보기

The PI3K/AKT pathway is activated by various stimuli (including insulin and IGF-1) and mediates signals for cell growth, cell survival, translation, and inhibition of apoptosis. PRAS40 (Proline-rich AKT substrate, 40 kDa) is a cytosolic protein that is phosphorylated at position Thr246 by AKT directly upon stimulation of the pathway. PRAS40 has been shown to bind to the mTORC1 complex and inhibit downstream signaling (i.e., phosphorylation of 4E-BP1 or p70S6K). LanthaScreen™ PRAS40 HEK293E is a human cell line which constitutively expresses GFP-PRAS40 fusion proteins.

The kinase substrate was introduced using lentiviral transduction followed by selection with blasticidin. This cell line is a clonal population isolated by flow cytometry using GFP fluorescence as a sorting marker. The PI3K/AKT pathway is known to be active in the highly insulin-responsive HEK293E cell background. Using this cell line, a homogenous (addition only) immunoassay has been developed in a 384-well format. The phosphorylation of PRAS40 at Thr246 is detected in cell lysates using a terbium-labeled phosphospecific antibody in a time-resolved FRET (TR-FRET) readout.

The performance of this assay has been tested using numerous experimental variables, including cell plating density, stimulation time, DMSO tolerance, and antibody incubation time. Under optimized conditions, the assay has been further validated and shows correct EC50 and IC50 values, with insulin as the primary agonist and PI-103 as the known inhibitor. Overall, the assay displays excellent statistical data (Z`-factor >0.6), high signal-to-background (response ratio), and is a robust cell-based readout of AKT signaling.

사양

대체 작용제Insulin

길항제IGF-1

어세이 입력Cell-based terbium phospho-specific activity (stable)

셀 상태Dividing Cells

유전자 기호PRAS40

일차 작용제Insulin

제품라인LanthaScreen™

수량1 Vial

판독End Point

리포터 유전자GFP (EmGFP)

타겟 입력PRAS40

System TypeLanthaScreen™

Druggable TargetSignaling Pathway

Unit SizeEach